These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A flow cytometry-based assay for screening FimH antagonists. Scharenberg M; Abgottspon D; Cicek E; Jiang X; Schwardt O; Rabbani S; Ernst B Assay Drug Dev Technol; 2011 Oct; 9(5):455-64. PubMed ID: 21675870 [TBL] [Abstract][Full Text] [Related]
12. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract? Scharf B; Schmidt TJ; Rabbani S; Stork C; Dobrindt U; Sendker J; Ernst B; Hensel A J Ethnopharmacol; 2020 Jul; 257():112889. PubMed ID: 32311481 [TBL] [Abstract][Full Text] [Related]
13. Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease. Mydock-McGrane LK; Hannan TJ; Janetka JW Expert Opin Drug Discov; 2017 Jul; 12(7):711-731. PubMed ID: 28506090 [TBL] [Abstract][Full Text] [Related]
14. CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection. Fortney KR; Smith SN; van Rensburg JJ; Brothwell JA; Gardner JJ; Katz BP; Ahsan N; Duerfeldt AS; Mobley HLT; Spinola SM Microbiol Spectr; 2022 Apr; 10(2):e0243021. PubMed ID: 35297652 [TBL] [Abstract][Full Text] [Related]
15. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Cusumano CK; Pinkner JS; Han Z; Greene SE; Ford BA; Crowley JR; Henderson JP; Janetka JW; Hultgren SJ Sci Transl Med; 2011 Nov; 3(109):109ra115. PubMed ID: 22089451 [TBL] [Abstract][Full Text] [Related]
16. Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract. Kurimura Y; Nishitani C; Ariki S; Saito A; Hasegawa Y; Takahashi M; Hashimoto J; Takahashi S; Tsukamoto T; Kuroki Y J Biol Chem; 2012 Nov; 287(47):39578-88. PubMed ID: 23012359 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists. Schwardt O; Rabbani S; Hartmann M; Abgottspon D; Wittwer M; Kleeb S; Zalewski A; Smieško M; Cutting B; Ernst B Bioorg Med Chem; 2011 Nov; 19(21):6454-73. PubMed ID: 21962988 [TBL] [Abstract][Full Text] [Related]
18. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation. Klein T; Abgottspon D; Wittwer M; Rabbani S; Herold J; Jiang X; Kleeb S; Lüthi C; Scharenberg M; Bezençon J; Gubler E; Pang L; Smiesko M; Cutting B; Schwardt O; Ernst B J Med Chem; 2010 Dec; 53(24):8627-41. PubMed ID: 21105658 [TBL] [Abstract][Full Text] [Related]
19. Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic Lewis AJ; Richards AC; Mendez AA; Dhakal BK; Jones TA; Sundsbak JL; Eto DS; Rousek AA; Mulvey MA Infect Immun; 2024 May; 92(5):e0008024. PubMed ID: 38534100 [TBL] [Abstract][Full Text] [Related]
20. Uropathogenic Alfuraiji N; Al-Hamami A; Ibrahim M; Rajab HK; Hussain BW J Med Life; 2022 May; 15(5):650-654. PubMed ID: 35815089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]